Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles) technology to broadly expand the number of organs, ...
People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...